These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16268458)

  • 1. Tissue engineering of heart valves--hype or hope?
    Stock UA
    Thromb Haemost; 2005 Sep; 94(3):469-70. PubMed ID: 16268458
    [No Abstract]   [Full Text] [Related]  

  • 2. Will heart valve tissue engineering change the world?
    Yacoub MH; Takkenberg JJ
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):60-1. PubMed ID: 16265355
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart valve tissue engineering.
    Neuenschwander S; Hoerstrup SP
    Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineering of heart valves: advances and current challenges.
    Mol A; Smits AI; Bouten CV; Baaijens FP
    Expert Rev Med Devices; 2009 May; 6(3):259-75. PubMed ID: 19419284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart valve tissue engineering.
    Vesely I
    Circ Res; 2005 Oct; 97(8):743-55. PubMed ID: 16224074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells.
    Schaefermeier PK; Cabeza N; Besser JC; Lohse P; Daebritz SH; Schmitz C; Reichart B; Sodian R
    ASAIO J; 2009; 55(1):86-92. PubMed ID: 19092668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular tissue engineering therapy: so near, so far?
    Tang GH; Fazel S; Weisel RD; Van Arsdell GS; Li RK
    Ann Thorac Surg; 2005 Jun; 79(6):1831-3. PubMed ID: 15919265
    [No Abstract]   [Full Text] [Related]  

  • 9. Performance of decellularized xenogeneic tissue in heart valve replacement.
    Stock UA; Schenke-Layland K
    Biomaterials; 2006 Jan; 27(1):1-2. PubMed ID: 16026824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering.
    Taylor PM; Allen SP; Dreger SA; Yacoub MH
    J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical In Vitro and In Vivo Models for Heart Valve Therapies.
    Taramasso M; Emmert MY; Reser D; Guidotti A; Cesarovic N; Campagnol M; Addis A; Nietlispach F; Hoerstrup SP; Maisano F
    J Cardiovasc Transl Res; 2015 Jul; 8(5):319-27. PubMed ID: 25968135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A central heart valve bank for transplantation of human heart valves].
    Thijssen HJ; Bos E; Persijn GG
    Ned Tijdschr Geneeskd; 1991 Nov; 135(45):2116-20. PubMed ID: 1944687
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac surgeon's primer: tissue-engineered cardiac valves.
    Hopkins R
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2007; ():125-35. PubMed ID: 17434004
    [No Abstract]   [Full Text] [Related]  

  • 14. Viewpoint: Heart valve engineering. Interview by James Butcher.
    Yacoub M
    Circulation; 2007 Aug; 116(8):f44-6. PubMed ID: 17709644
    [No Abstract]   [Full Text] [Related]  

  • 15. ["Tissue engineering": Cultivated heart valves are still a future vision].
    Fath R
    Dtsch Med Wochenschr; 2003 Apr; 128(17):912. PubMed ID: 12749352
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering.
    Schoen FJ
    Circulation; 2008 Oct; 118(18):1864-80. PubMed ID: 18955677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
    Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
    Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine heterograft heart valves.
    Pagliero KM
    Nurs Times; 1975 Jun; 71(24):925-7. PubMed ID: 1134978
    [No Abstract]   [Full Text] [Related]  

  • 19. Current status of heart valve replacement.
    Pluth JR; McGoon DC
    Mod Concepts Cardiovasc Dis; 1974 Jan; 43(1):65-70. PubMed ID: 4591063
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue engineering therapy for cardiovascular disease.
    Nugent HM; Edelman ER
    Circ Res; 2003 May; 92(10):1068-78. PubMed ID: 12775655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.